Restrictions on interactions between doctors and industry could ultimately hurt patients.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21872108.
- Also identified by DOI 10.1016/j.jvs.2011.05.102.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Physician-industry collaboration has led to a diverse array of therapeutic advancements that have benefitted a broad spectrum of patient populations. Evolving regulations, both institutional and governmental, aiming to govern interactions between physicians and pharmaceutical and medical device manufacturers have become increasingly prevalent. Emerging data suggest that restrictions on physician-industry collaboration have the potential to harm patient care by degrading innovation and stifling medical education. The following article reviews the effects of legislation on medical innovation as well as the impact on continuing medical education.
Medical subject headings
- Health Care Sector
- Health Policy
- Interinstitutional Relations
- Interprofessional Relations
- Quality of Health Care